Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study-Reference-Cited by-同舟云学术

Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study

Published:2020-12-22 Issue:7 Volume:21 Page:2532-2542
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Walti Laura N.¹^ORCID,Mugglin Catrina¹^ORCID,Sidler Daniel²^ORCID,Mombelli Matteo³^ORCID,Manuel Oriol³^ORCID,Hirsch Hans H.⁴^ORCID,Khanna Nina⁴^ORCID,Mueller Nicolas⁵^ORCID,Berger Christoph⁶^ORCID,Boggian Katia⁷,Garzoni Christian⁸,Neofytos Dionysios⁹^ORCID,Delden Christian⁹^ORCID,Hirzel Cédric¹^ORCID,

Affiliation:

1. Department of Infectious Diseases Inselspital, Bern University Hospital, University of Bern Bern Switzerland

2. Department of Nephrology and Hypertension Inselspital, Bern University Hospital, University of Bern Bern Switzerland

3. Transplantation Center and Service of Infectious Diseases Lausanne University Hospital (CHUV) Lausanne Switzerland

4. Division of Infectious Diseases and Hospital Epidemiology University and University Hospital of Basel Basel Switzerland

5. Division of Infectious Diseases and Hospital Epidemiology University Hospital Zurich and University Zurich Zurich Switzerland

6. Division of Infectious Diseases and Hospital Epidemiology University Children's Hospital Zurich Zurich Switzerland

7. Division of Infectious Diseases and Hospital Hygiene Cantonal Hospital St. Gallen St. Gallen Switzerland

8. Clinic of Internal Medicine and Infectious Diseases Clinica Luganese Lugano Switzerland

9. Transplant Infectious Diseases Unit, Faculty of Medicine University Hospitals of Geneva Geneva Switzerland

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.16423

Reference58 articles.

1. Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?

2. De Novo Malignancy After Solid Organ Transplantation in Children

3. Lymphomas After Solid Organ Transplantation: A Collaborative Transplant Study Report

4. Low 5‐year cumulative incidence of post‐transplant lymphoproliferative disorders after solid organ transplantation in Switzerland;Steiner R;Swiss Med Wkly,2018

5. Epstein-Barr Virus Infection and Posttransplant Lymphoproliferative Disorder

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of induction therapy on the risk of posttransplant lymphoproliferative disorder in adult kidney transplant recipients with donor-recipient serological Epstein-Barr virus mismatch;American Journal of Transplantation;2024-08

2. Effect of pre‐emptive rituximab on EBV DNA levels and prevention of post‐transplant lymphoproliferative disorder in pediatric kidney transplant recipients: A case series from the pediatric nephrology research consortium;Pediatric Transplantation;2024-04-02

3. Epstein-Barr virus associated colitis in kidney transplant patients: a case series;Infectious Diseases;2024-03-09

4. Incidence of De Novo Post-Transplant Malignancies in Thai Adult Kidney Transplant Recipients: A Single-Center, Population-Controlled, Retrospective Cohort Study at the Highest Volume Kidney Transplant Center in Thailand;Transplant International;2024-02-26

5. Temporal Trends, Risk Factors, and Clinical Outcomes of De Novo Lymphoproliferative Disorders After Heart Transplantation;JACC: Heart Failure;2024-02